Craig Hendrix is currently the Welcome Professor and Director, Division of Clinical Pharmacology, Johns Hopkins University School of Medicine. He trained in infectious diseases and clinical pharmacology at Hopkins before a career in the US Air Force and at Johns Hopkins. Dr. Hendrix’s primary research focus is clinical pharmacology of HIV pre-exposure prophylaxis. Among other research projects, he’s involved as Principal Investigator or Project Leader in a variety of early phase PrEP program project grants funded through the DAIDS Integrated Clinical/Preclinical HIV Topical Microbicide Program. He also serves as director of the pharmacology group for the MTN and HPTN.